Acerca de
Program
08.45-09.20
09.20-09.30
09.30-10.00
10.00-10.15
10.15-10.45
10.45-11.00
11.00-11.20
11.20-11.40
11.40-12.10
12.10-12.30
12.30-12.40
12.40-13.40
13.40-14.10
14.10-14.40
14.40-14.50
14.50-15.10
15.10-15.30
15.30-15.45
15.45
Registration
Welcome & Introduction - H.L.A. Janssen
Portal hypertension: Baveno VII and beyond - Chair S. Darwish Murad
Beta blockade all patients with portal hypertension? - C. Ripoll
Statins for all patients with cirrhosis? - R. Maan
Treatment of hepatic encephalopathy beyond lactulose - J.G. Langendonk
Secondary prophylaxis for SBP with noroxin or rifaximin - R.B. Takkenberg
Discussion
Coffee break
State of the art lectures part 1 - Chair M.J. Sonneveld
Steroids in alcoholic hepatitis: yes, no or with antibiotics? - A. Louvet
When to start and when to stop nucleo(s)tide analogues in chronic hepatitis B - H.L.A. Janssen
Discussion
Lunch
State of the art lectures part 2 - Chair R.J. de Knegt
Porto-sinusoidal vascular disorder: a new name for an old disease - P.E. Rautou
New pharmacological therapies for NAFLD/NASH, all diabetics with NASH on GLP-1? - S. Francque
Discussion
Liver tumors - Chair R.A. de Man
HCC surveillance; imaging, AFP and beyond - D. Sprengers
Liver transplantation for perihilar cholangiocarcinoma: indication and outcome - R.J. Porte
Discussion and closing remarks - H.L.A. Janssen
Drinks